Velma Scantlebury

General Practice physician in Newark, Delaware — also lists obesity medicine in the CMS registry.

Practice Details

Address
4735 Ogletown Stanton Rd
Newark, DE 19713
Geocoded location: 39.6888, -75.6751
Phone
302-623-3866
Taxonomy
Surgery
Credential
MD
NPPES Enumeration
Listed with NPPES since 2006
NPPES Record Updated
June 2023

About This Clinician

Velma Scantlebury is a General Practice physician in Newark whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 60 Surgery practices in Newark carrying this exact taxonomy in our directory.

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Delaware addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Delaware telehealth partners:

Featured Partners · Newark

Featured GLP-1 providers serving Newark

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.8

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  2. Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →
  3. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  4. Compounded from

    $79/mo

    Save $1,270/mo vs Wegovy
    Get started →
  5. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  6. Compounded from

    $149/mo

    Save $1,200/mo vs Wegovy
    Get started →

See more Newark options on the Newark clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Newark obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions